The recommended initial oral treatment regimen in the US includes INH 300 mg, ethambutol 15 to 25 mg / kg (maximum 2.5 g), and rifampin 600 mg. All pregnant and breastfeeding women receiving INH should also receive pyridoxine 25 to 30 mg orally.